See up to 3 months of HROW. The 7-day demo opens the 1M and 3M ranges and puts HROW on your watchlist.
Start 7-day demoLatest HROW insider trades
Amir Shojaei - OfficerOpen-market sale$450K- Adrienne L. Graves - DirectorOpen-market purchase$31K
About HARROW, INC. (HROW)
HARROW, INC. files with the SEC under CIK 0001360214 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
HROW Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 11,250 | $450K |
| Option exercise | 2 | 22,500 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
HROW insider transactions (Form 4)
3521 Form 4 filings on record, the earliest from Apr 7, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Amir Shojaei - Officer | Option exercise | Common Stock | 11,250 | $35.96 | $405K | |
| Amir Shojaei - Officer | Open-market sale | Common Stock | 11,250 | $40.00 | $450K | |
| Amir Shojaei - Officer | Option exercise | Stock Option (Right to Buy) | 11,250 | $35.96 | $405K | |
| Perry J. Sternberg - Director | Grant or award | RSU | 5,248 | $0.00 | - | |
| Lauren P. Silvernail - Director | Grant or award | RSU | 5,248 | $0.00 | - | |
| Adrienne L. Graves - Director | Grant or award | RSU | 5,248 | $0.00 | - | |
| Adrienne L. Graves - Director | Open-market purchase | Common Stock | 1,000 | $31.07 | $31K | |
| Lauren P. Silvernail - Director | Open-market purchase | Common Stock | 1,000 | $31.00 | $31K | |
| Amir Shojaei - Officer | Grant or award | Restricted Stock Units | 10,000 | $0.00 | - | |
 Mark L. Baum - Officer | Open-market purchase | Common Stock | 10,000 | $30.20 footnote F1 | $302K | |
| ||||||
 Andrew R. Boll - Officer | Open-market purchase | Common Stock | 3,500 | $29.90 footnote F1 | $105K | |
| ||||||
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 4,263 | $39.67 footnote F4 | $169K | |
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 59,000 | $39.15 footnote F3 | $2.31M | |
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 1,309 | $39.15 footnote F3 | $51K | |
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 134,000 | $39.67 footnote F4 | $5.32M | |
| ||||||
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 5,000 | $54.18 | $271K | |
| Patrick William Sullivan - Officer | Grant or award | RSU | 25,000 | $0.00 | - | |
| Patrick William Sullivan - Officer | Grant or award | RSU | 15,000 | $0.00 | - | |
| Opaleye Management Inc. - 10% Owner | Open-market sale | Common Stock, par value $0.001 per share | 20,000 | $53.35 | $1.07M | |
| Andrew R. Boll - Officer | Option exercise | Common Stock | 60,000 | $3.95 | $237K | |
| Andrew R. Boll - Officer | Tax withholding / forfeiture | Common Stock | 26,665 | $47.06 | $1.25M | |
| Andrew R. Boll - Officer | Option exercise | Stock Option (Right to Buy) | 60,000 | $0.00 | - | |
| Mark L. Baum - Officer | Option exercise | Common Stock | 180,000 | $3.95 | $711K | |
| Mark L. Baum - Officer | Tax withholding / forfeiture | Common Stock | 79,994 | $47.06 | $3.76M | |
| Mark L. Baum - Officer | Option exercise | Stock Option (Right to Buy) | 180,000 | $0.00 | - | |
| Randall E. Pollard - Officer | Grant or award | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Mark L. Baum - Officer | Option exercise | Common stock | 600,000 | $7.87 | $4.72M | |
| Mark L. Baum - Officer | Tax withholding / forfeiture | Common stock | 313,338 | $37.08 | $11.62M | |
| Mark L. Baum - Officer | Option exercise | Stock Option (Right to Buy) | 600,000 | $0.00 | - | |
| Andrew R. Boll - Officer | Grant or award | RSU | 405,750 | $0.00 | - | |
| Mark L. Baum - Officer | Grant or award | RSU | 889,500 | $0.00 | - | |
| Lauren P. Silvernail - Director | Grant or award | RSU | 7,339 | $0.00 | - | |
| Mark L. Baum - Officer | Option exercise | Common Stock | 762,300 | $0.00 | - | |
| Mark L. Baum - Officer | Tax withholding / forfeiture | Common Stock | 300,363 | $23.09 | $6.94M | |
| Mark L. Baum - Officer | Option exercise | Performance Stock Unit | 762,300 | $0.00 | - | |
Item 1.01, 2.01, 7.01, 9.01
Item 5.02, 9.01
Item 2.02, 7.01, 9.01
Item 1.01, 7.01, 9.01
Recent HROW Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| AMIR SHOJAEI | CHIEF SCIENTIFIC OFFICER | 11,250 | $450K | View on EDGAR |
HROW insider trading FAQ
What is the latest insider trade for HROW?
HARROW, INC. (HROW) had 1 insider filing in the last 90 days, with the most recent on 2026-08-17. The full record for HROW runs to 21 Form 4 filings, the earliest from 2025-04-07. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying HROW stock?
No insider purchases of HROW were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling HROW stock?
1 insider sale of HROW was filed in the last 90 days, totaling $450K.
Where can I see HROW SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects HROW Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Amir Shojaei view on EDGAR
- - Perry J. Sternberg view on EDGAR
- - Lauren P. Silvernail view on EDGAR
- - Adrienne L. Graves view on EDGAR
- - Adrienne L. Graves view on EDGAR
- - Lauren P. Silvernail view on EDGAR
- - Amir Shojaei view on EDGAR
- - Mark L. Baum view on EDGAR
- - Andrew R. Boll view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where HROW's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow HROW with a 7-day demo
- HROW on your watchlist
- Every HROW Form 4 filing on record
- Up to 3 months of HROW price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
